2.1 Absence of nausea |
5 |
258 |
Risk Ratio (IV, Random, 95% CI) |
1.46 [0.67, 3.15] |
2.1.1 Prochlorperazine |
5 |
258 |
Risk Ratio (IV, Random, 95% CI) |
1.46 [0.67, 3.15] |
2.2 Absence of nausea (subgroup analysis 2) |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
2.2.1 Nabilone |
3 |
141 |
Risk Ratio (IV, Random, 95% CI) |
1.41 [0.33, 6.03] |
2.2.2 Dronabinol |
2 |
117 |
Risk Ratio (IV, Random, 95% CI) |
2.38 [0.21, 26.91] |
2.3 Absence of vomiting |
4 |
209 |
Risk Ratio (IV, Random, 95% CI) |
1.11 [0.86, 1.44] |
2.3.1 Prochlorperazine |
4 |
209 |
Risk Ratio (IV, Random, 95% CI) |
1.11 [0.86, 1.44] |
2.4 Absence of vomiting (subgroup analysis 2) |
4 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
2.4.1 Nabilone |
2 |
93 |
Risk Ratio (IV, Random, 95% CI) |
1.55 [0.39, 6.24] |
2.4.2 Dronabinol |
2 |
116 |
Risk Ratio (IV, Random, 95% CI) |
1.05 [0.64, 1.71] |
2.5 Absence of nausea and vomiting |
4 |
414 |
Risk Ratio (IV, Random, 95% CI) |
2.00 [0.74, 5.38] |
2.5.1 Prochlorperazine |
4 |
414 |
Risk Ratio (IV, Random, 95% CI) |
2.00 [0.74, 5.38] |
2.6 Absence of nausea and vomiting (subgroup analysis 1) |
4 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
2.6.1 Cannabis naive |
2 |
116 |
Risk Ratio (IV, Random, 95% CI) |
1.10 [0.70, 1.72] |
2.6.2 Prior cannabis use |
2 |
298 |
Risk Ratio (IV, Random, 95% CI) |
17.98 [2.44, 132.43] |
2.7 Absence of nausea and vomiting (subgroup analysis 2) |
4 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
2.7.1 Nabilone |
1 |
226 |
Risk Ratio (IV, Random, 95% CI) |
17.00 [0.99, 291.06] |
2.7.2 Dronabinol |
3 |
188 |
Risk Ratio (IV, Random, 95% CI) |
1.44 [0.62, 3.31] |
2.8 Dizziness |
9 |
743 |
Risk Ratio (IV, Random, 95% CI) |
2.54 [1.91, 3.37] |
2.8.1 Domperidone |
1 |
38 |
Risk Ratio (IV, Random, 95% CI) |
2.75 [1.06, 7.12] |
2.8.2 Prochlorperazine |
7 |
675 |
Risk Ratio (IV, Random, 95% CI) |
2.36 [1.82, 3.07] |
2.8.3 Metoclopramide |
1 |
30 |
Risk Ratio (IV, Random, 95% CI) |
12.00 [1.78, 81.06] |
2.9 Dysphoria |
3 |
192 |
Risk Ratio (IV, Random, 95% CI) |
7.17 [1.33, 38.84] |
2.9.1 Prochloperazine |
3 |
192 |
Risk Ratio (IV, Random, 95% CI) |
7.17 [1.33, 38.84] |
2.10 Euphoria |
4 |
358 |
Risk Ratio (IV, Random, 95% CI) |
8.89 [2.05, 38.63] |
2.10.1 Domperidone |
1 |
38 |
Risk Ratio (IV, Random, 95% CI) |
5.00 [0.26, 97.70] |
2.10.2 Prochlorperazine |
2 |
280 |
Risk Ratio (IV, Random, 95% CI) |
17.97 [2.42, 133.37] |
2.10.3 Chlorpromazine |
1 |
40 |
Risk Ratio (IV, Random, 95% CI) |
3.00 [0.13, 69.52] |
2.11 'Feeling high' |
5 |
419 |
Risk Ratio (IV, Random, 95% CI) |
5.90 [3.42, 10.17] |
2.11.1 Prochlorperazine |
4 |
389 |
Risk Ratio (IV, Random, 95% CI) |
6.18 [3.52, 10.85] |
2.11.2 Metoclopramide |
1 |
30 |
Risk Ratio (IV, Random, 95% CI) |
3.00 [0.35, 25.68] |
2.12 Hallucinations |
2 |
144 |
Risk Ratio (IV, Random, 95% CI) |
5.39 [0.66, 43.68] |
2.12.1 Prochlorperazine |
2 |
144 |
Risk Ratio (IV, Random, 95% CI) |
5.39 [0.66, 43.68] |
2.13 Postural hypotension |
6 |
413 |
Risk Ratio (IV, Random, 95% CI) |
2.40 [0.88, 6.53] |
2.13.1 Domperidone |
1 |
38 |
Risk Ratio (IV, Random, 95% CI) |
4.00 [0.49, 32.57] |
2.13.2 Prochlorperazine |
3 |
305 |
Risk Ratio (IV, Random, 95% CI) |
1.22 [0.52, 2.89] |
2.13.3 Metoclopramide |
1 |
30 |
Risk Ratio (IV, Random, 95% CI) |
17.00 [1.07, 270.41] |
2.13.4 Chlorpromazine |
1 |
40 |
Risk Ratio (IV, Random, 95% CI) |
7.00 [0.95, 51.80] |
2.14 Paranoia |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
2.14.1 Prochlorperazine |
1 |
42 |
Risk Ratio (IV, Random, 95% CI) |
3.00 [0.13, 69.70] |
2.15 Sedation |
11 |
1055 |
Risk Ratio (IV, Random, 95% CI) |
1.33 [1.08, 1.64] |
2.15.1 Domperidone |
1 |
38 |
Risk Ratio (IV, Random, 95% CI) |
1.22 [0.66, 2.25] |
2.15.2 Prochlorperazine |
8 |
947 |
Risk Ratio (IV, Random, 95% CI) |
1.44 [1.18, 1.76] |
2.15.3 Metoclopramide |
1 |
30 |
Risk Ratio (IV, Random, 95% CI) |
0.93 [0.73, 1.18] |
2.15.4 Chlorpromazine |
1 |
40 |
Risk Ratio (IV, Random, 95% CI) |
1.71 [0.85, 3.44] |
2.16 Depression |
3 |
317 |
Risk Ratio (IV, Random, 95% CI) |
0.81 [0.51, 1.28] |
2.16.1 Prochlorperazine |
3 |
317 |
Risk Ratio (IV, Random, 95% CI) |
0.81 [0.51, 1.28] |
2.17 Participant preference |
9 |
799 |
Risk Ratio (IV, Random, 95% CI) |
2.76 [1.88, 4.03] |
2.17.1 Prochlorperazine |
7 |
695 |
Risk Ratio (IV, Random, 95% CI) |
3.24 [2.23, 4.72] |
2.17.2 Metoclopramide |
1 |
64 |
Risk Ratio (IV, Random, 95% CI) |
1.20 [0.61, 2.37] |
2.17.3 Chlorpromazine |
1 |
40 |
Risk Ratio (IV, Random, 95% CI) |
2.00 [0.83, 4.81] |
2.18 Withdrawal for any reason |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
2.18.1 Prochlorperazine |
1 |
42 |
Risk Ratio (IV, Random, 95% CI) |
3.50 [1.38, 8.89] |
2.19 Withdrawal due to adverse event |
6 |
740 |
Risk Ratio (IV, Random, 95% CI) |
3.16 [1.26, 7.93] |
2.19.1 Domperidone |
1 |
76 |
Risk Ratio (IV, Random, 95% CI) |
3.00 [0.13, 71.40] |
2.19.2 Prochlorperazine |
5 |
664 |
Risk Ratio (IV, Random, 95% CI) |
3.90 [1.25, 12.20] |
2.20 Withdrawal due to lack of efficacy |
2 |
118 |
Risk Ratio (IV, Random, 95% CI) |
0.97 [0.04, 20.93] |
2.20.1 Domperidone |
1 |
76 |
Risk Ratio (IV, Random, 95% CI) |
0.14 [0.01, 2.67] |
2.20.2 Prochlorperazine |
1 |
42 |
Risk Ratio (IV, Random, 95% CI) |
3.50 [1.38, 8.89] |